Research and Development of Ad26. ZEBOV
Awarded Award Notice Posted
- Solicitation number
- CBRN-BAA-13-100-SOL-00013
- Agency
- Immediate Office of the Secretary Department of Health and Human Services
- Awarded
- to Janssen Vaccines & Prevention B.V.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- HHSO100201500008C Federal contract award
- NAICS code
- 541711 Research and Development in Biotechnology
- PSC
- Not on record
Notice details come from SAM.gov. Updated .
Notice text
Added: Sep 10, 2015 7:25 pm Award of a Total Estimated Cost Plus Fixed Fee (CPFF) contract to Crucell Holland, B.V. (a Janssen Pharmaceutical Company) for the research and development of Ad26.ZEBOV.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Clinical development of Ceftobiprole | Award Notice | |
| Development of a Single Dose Intranasal Post-Exposure Prophylaxis Vaccine for Inhalation Anthrax | Award Notice | |
| Research and Development of Ad26. ZEBOV | Award Notice | |
| Advanced Research and Development of NuThrax or AV7909 | Award Notice |
And 1 more award notice.
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity